Records containing: Short Bowel Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3, Double-blind, Randomized, Parallel Group, Placebo-controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice Weekly, Followed by a Long-term, Open-label Safety Evaluation in Patients With Short Bowel Syndrome-intestinal Failure (SBS-IF)
-
CLINICAL_TRIALS study record update · 2026-04-13Special Drug Use Investigation of Revestive Subcutaneous Injection 3.8 mg (All-case Surveillance)
-
CLINICAL_TRIALS study record update · 2026-03-02A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
-
CLINICAL_TRIALS study record update · 2026-02-12SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
-
CLINICAL_TRIALS study record update · 2026-02-12Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-02A 104-Week, Multicenter, Single-Arm, Long-Term, Phase 3 Extension Trial Investigating the Safety and Efficacy of Glepaglutide in Adult Patients With Short Bowel Syndrome (SBS) Completing the EASE SBS 2 Trial
-
CLINICAL_TRIALS study record update · 2026-01-30A Double-Blind Phase 3 Extension Trial Assessing the Long Term Safety and Efficacy of Glepaglutide in Patients With Short Bowel Syndrome (SBS)
-
CLINICAL_TRIALS study record update · 2026-01-28Palliative Care Needs of Children With Rare Diseases and Their Families
-
CLINICAL_TRIALS study record update · 2025-12-30A 90 Day Observational Study as an Extension to the Phase 3, Open Labeled, Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on PN
-
CLINICAL_TRIALS study record update · 2025-12-17A 90 Day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on Parenteral Nutrition
-
CLINICAL_TRIALS study record update · 2025-12-11A Multicenter, Proof-of-concept, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15912 (Sonefpeglutide) in Adult Subjects With Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
-
CLINICAL_TRIALS study record update · 2025-11-19Gastrointestinal Hormone Secretion, Bile Acid Homeostasis, Intestinal Permeability and Bacterial Translocation in Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Alcoholic Liver Cirrhosis and Short Bowel Syndrome (SBS)
-
CLINICAL_TRIALS study record update · 2025-10-10A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-10-08A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-10-03Effect of Parenteral Nutrition/Fluids on FibroScan Results in Patients With Short Bowel Syndrome
-
CLINICAL_TRIALS study record update · 2025-09-25Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
-
CLINICAL_TRIALS study record update · 2025-09-22Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome (SBS) Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.
-
CLINICAL_TRIALS study record update · 2025-09-11A Monocentric Single-arm Study to Characterize the Long-term Safety, Efficacy, and Pharmacodynamic of GLP-2 Analog (Revestive®) in the Management of Short Bowel Syndrome Pediatric Patients on Home-parenteral Nutrition (HPN)
-
CLINICAL_TRIALS study record update · 2025-07-09An Open-label, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of 0.05 mg/kg/Day Subcutaneous Teduglutide Following Treatment of Short Bowel Syndrome for 24 Weeks in Chinese Adults Who Are Dependent on Parenteral Support
-
CLINICAL_TRIALS study record update · 2025-07-02An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
-
CLINICAL_TRIALS study record update · 2025-06-18A Multicenter, Open-label, Metabolic Balance Study to Evaluate the Effects of Apraglutide on Intestinal Absorption in Adult Subjects With Short Bowel Syndrome, Intestinal Failure (SBS-IF), and Colon-in-Continuity (CIC)
-
CLINICAL_TRIALS study record update · 2025-06-12A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study of 2 Doses of Crofelemer for the Treatment of Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
-
CLINICAL_TRIALS study record update · 2025-05-29Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2025-05-16Randomized Prospective Trial Comparing Intralipid Versus SMOFlipid in New HPN Patients.
-
CLINICAL_TRIALS study record update · 2024-11-27A Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Apraglutide in Adult Subjects With Short Bowel Syndrome and Intestinal Failure (SBS-IF)